Red X iconGreen tick iconYellow tick icon

Mark RichardsProfessor

BA (Massey) MB ChB (Otago) MD(Otago,) PhD(Otago) DSc (Otago) FRACP FRCP FRSNZ

Department of Medicine
University of Otago, Christchurch
PO Box 4345
New Zealand


Mark Richards is the director of the Christchurch Heart Institute.

He coordinates and directs multi-disciplinary programmes of grant-funded translational cardiovascular research which seek to improve diagnostic, prognostic and therapeutic options in heart disease.

He is pursuing studies of epidemiological, molecular biological, neurohormonal and therapeutic aspects of acute and chronic cardiovascular disorders including hypertension, coronary syndromes, and the full spectrum of heart failure.

Richards holds the Heart Foundation of New Zealand's Chair in Cardiovascular Studies.

He also holds joint appointments at the University of Otago and the National University of Singapore's Cardiovascular Research Institute.
Email (University of Singapore)

Current roles

Research interests

  • Neurohormonal physiology and pathophysiology in cardiovascular health and disease
  • Heart Failure
  • Acute Coronary Syndromes
  • Hypertension
  • Vasoactive Hormones
  • The Cardiac Natriuretic Peptides


Koo, C.-Y., Zheng, H., Tan, L.-L., Foo, L.-L., Shih, E., Hausenloy, D. J., … Richards, A. M., … Chan, M. Y. (2023). Global Registry of Acute Coronary Events score underestimates post-acute coronary syndrome mortality among cancer patients. Cancers, 15, 5222. doi: 10.3390/cancers15215222

Kalailingam, P., Mohd-Kahliab, K.-H., Ngan, S. C., Iyappan, R., Melekh, E., Lu, T., … Richards, A. M., … Sze, S. K. (2023). Immunotherapy targeting isoDGR-protein damage extends lifespan in a mouse model of protein deamidation. EMBO Molecular Medicine, e18526. Advance online publication. doi: 10.15252/emmm.202318526

Wong, L. L., Fadzil, A. B., Chen, Q., Rademaker, M. T., Charles, C. J., Richards, A. M., & Wang, P. (2023). Interrogating the role of miR-125b and its 3’isomiRs in protection against hypoxia. International Journal of Molecular Sciences, 24, 16015. doi: 10.3390/ijms242116015

Devlin, G., Tukuitonga, C., Grey, C., Richards, M., Rolleston, A., Doughty, R., Legget, M., & Mann, J. (2023). Call to action: The urgent need for a heart health plan in New Zealand. New Zealand Medical Journal/Te ara tika o te hauora hapori, 136(1585), 103-108. Retrieved from

Rademaker, M. T., Scott, N. J. A., Charles, C. J., & Richards, A. M. (2023). Combined inhibition of phosphodiesterases 5 and 9 in experimental heart failure. JACC: Heart Failure. Advance online publication. doi: 10.1016/j.jchf.2023.08.028

Back to top